The American pharmaceutical company Johnson & Johnson became, on Monday, the fourth company to approach Health Canada to have its vaccine against COVID-19 evaluated.
“Today, Johnson & Johnson applied to Health Canada for their COVID-19 vaccine. This is the 4e vaccine that Health Canada will evaluate, ”Federal Health Minister Patty Hajdu briefly announced on Twitter.
Unlike some of its rivals, the pharmaceutical has not yet released the results of phase 3 of its tests. Preliminary results showed that up to 98% of guinea pigs developed an immune response after receiving his vaccine and still had antibodies four weeks after receiving the injection.
Canada has already placed an order totaling 10 million doses from Johnson & Johnson, with the possibility of purchasing an additional 28 million doses.
Ottawa is already studying vaccines from Pfizer / BioNTech, Moderna and AstraZeneca. The federal government has reserved 60 million doses of vaccines from these companies, with options to purchase 92 million more.
These were the details of the news Johnson & Johnson’s turn to get their vaccine approved for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
